Aclarion Past Earnings Performance

Past criteria checks 0/6

Aclarion's earnings have been declining at an average annual rate of -4.5%, while the Healthcare Services industry saw earnings growing at 2.8% annually. Revenues have been growing at an average rate of 14.7% per year.

Key information

-4.5%

Earnings growth rate

49.6%

EPS growth rate

Healthcare Services Industry Growth1.7%
Revenue growth rate14.7%
Return on equityn/a
Net Margin-6,513.4%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Aclarion makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:ACON Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-541
30 Sep 230-541
30 Jun 230-541
31 Mar 230-751
31 Dec 220-741
30 Sep 220-851
30 Jun 220-941
31 Mar 220-621
31 Dec 210-621
30 Sep 210-521
30 Jun 210-511
31 Mar 210-511
31 Dec 200-511
31 Dec 190-522

Quality Earnings: ACON is currently unprofitable.

Growing Profit Margin: ACON is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ACON is unprofitable, and losses have increased over the past 5 years at a rate of 4.5% per year.

Accelerating Growth: Unable to compare ACON's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ACON is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (15.4%).


Return on Equity

High ROE: ACON's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.